The increasing popularity in this medication, specifically the B974 formulation at 30mg, presents notable challenges within Australia . While copyright is not widely obtainable through conventional channels in Australia , reports suggest its emergence on the copyright. This lack of controlled supply fuels anxieties surrounding possible misuse , ill